These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 3935096)
1. The effects of pantethine on lipid and lipoprotein abnormalities in survivors of cerebral infarction. Murai A; Miyahara T; Tanaka T; Sako Y; Nishimura N; Kameyama M Artery; 1985; 12(4):234-43. PubMed ID: 3935096 [TBL] [Abstract][Full Text] [Related]
2. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R Artery; 1982; 10(4):266-85. PubMed ID: 7181672 [TBL] [Abstract][Full Text] [Related]
3. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin. Lijnen P; Celis H; Desager JP; Fagard R J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885 [TBL] [Abstract][Full Text] [Related]
4. [Effect of pantethine on the lipoprotein abnormalities in survivors of cerebral infarction (author's transl)]. Murai A; Miyahara T; Tanaka T; Sako Y; Kameyama M; Nishimura N Nihon Ronen Igakkai Zasshi; 1980 Nov; 17(6):624-9. PubMed ID: 7206301 [No Abstract] [Full Text] [Related]
6. Lipoprotein changes in children after liver transplantation: mild hypertriglyceridemia and a decrease in HDL3/HDL2 ratio. Granot E Hepatology; 1998 Jan; 27(1):175-80. PubMed ID: 9425934 [TBL] [Abstract][Full Text] [Related]
7. Characterization of plasma lipoproteins in survivors of cerebral infarction. Murai A; Miyahara T; Tanaka T; Kameyama M Tohoku J Exp Med; 1986 Jan; 148(1):57-64. PubMed ID: 3705064 [TBL] [Abstract][Full Text] [Related]
8. [Value of the analysis of lipoproteins after myocardial infarction]. Dewailly P; Mellin D; Moulin S; Rouget JP; Sezille G; Jaillard J Presse Med; 1983 Jul 9-16; 12(29):1807-10. PubMed ID: 6224195 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein changes induced by pantethine in hyperlipoproteinemic patients: adults and children. Bertolini S; Donati C; Elicio N; Daga A; Cuzzolaro S; Marcenaro A; Saturnino M; Balestreri R Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):630-7. PubMed ID: 3098691 [TBL] [Abstract][Full Text] [Related]
10. Influence of cholesterol-lowering on plasma membrane lipids and function. Lijnen P; Echevaría-Vázquez D; Petrov V Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244 [TBL] [Abstract][Full Text] [Related]
11. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia. Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H Artery; 1993; 20(1):1-18. PubMed ID: 8447724 [TBL] [Abstract][Full Text] [Related]
12. Improved lipoprotein surface and core lipid composition following intraperitoneal insulin delivery in insulin-dependent diabetes mellitus. Bagdade JD; Dunn FL Diabetes Metab; 1996 Dec; 22(6):420-6. PubMed ID: 8985650 [TBL] [Abstract][Full Text] [Related]
13. [Concentration of lipids and apolipoproteins A-I, A-II and E in blood plasma of men with chronic alcoholism]. Triufanov VF; Usatenko MS; Bokiĭ IV Vopr Med Khim; 1981; 27(3):397-402. PubMed ID: 6792781 [TBL] [Abstract][Full Text] [Related]
14. [Disruption of the cholesterol-transport function of lipoproteins in the blood plasma of patients with ischemic heart disease]. Gerasimova EN; Perova NV; Kurdanov KhA; Polesskiĭ VA Vopr Med Khim; 1984; 30(6):71-6. PubMed ID: 6528538 [TBL] [Abstract][Full Text] [Related]
15. [Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL]. Breier C; Lisch HJ; Drexel H; Braunsteiner H Schweiz Med Wochenschr; 1984 Mar; 114(9):288-91. PubMed ID: 6710113 [TBL] [Abstract][Full Text] [Related]
16. [Serum lipids and lipoproteins in patients with cerebrovascular disorders]. Lorenc J; Kościuk N Przegl Lek; 1989; 46(9):681-5. PubMed ID: 2595002 [TBL] [Abstract][Full Text] [Related]
18. Effect of metabolic control of the serum lipid and lipoprotein levels on insulin-dependent diabetes mellitus. Romics L; Karádi I; Rozenberczki M; Kammerer L Acta Med Acad Sci Hung; 1982; 39(3-4):117-23. PubMed ID: 6764327 [TBL] [Abstract][Full Text] [Related]
19. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients. Ybarra J; James RW; Makoundou V; Bioletto S; Golay A Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380 [TBL] [Abstract][Full Text] [Related]
20. Serum lipoproteins and apolipoproteins A I and A II in male patients with peripheral arterial insufficiency. Angquist KA; Johnson O; Ericsson M; Tollin C Acta Chir Scand; 1982; 148(8):675-8. PubMed ID: 6820598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]